Common and differentially expressed long noncoding RNAs for the characterization of high and low grade bladder cancer.
Common and differentially expressed long noncoding RNAs for the characterization of high and low grade bladder cancer.
复制标题
DOI:
10.1016/j.gene.2016.07.042
复制
发表时间:
2016-10
期刊:
影响因子:
3.5
通讯作者:
Miao Wang;Xing-yuan Xiao;Fuqing Zeng;Fei Xie;Yebin Fan;Chao Huang;Guosong Jiang;Liang Wang
中科院分区:
文献类型:
--
作者:
Miao Wang;Xing-yuan Xiao;Fuqing Zeng;Fei Xie;Yebin Fan;Chao Huang;Guosong Jiang;Liang Wang
Our study aimed to explore long non-coding RNAs (lncRNAs) contributing to the development of bladder cancer, as well as to identify more critical DEGs and lncRNAs that would characterize low- and high-grade bladder cancer. The microarray data of GSE55433 was downloaded from Gene Expression Omnibus database, including 57 urothelial cancer samples (23 low-grade NMI, 14 high-grade NMI and 20 invasive tumors) and 26 normal controls. The differentially expressed genes (DEGs) and differentially expressed lncRNAs were identified in 3 groups (low-grade NMIvs.normal, high-grade NMIvs.normal and invasive UCvs.normal). Functional enrichment analysis was performed upon the DEGs in different groups. Besides, protein-protein interaction (PPI) network was constructed based on common DEGs and remaining DEGs in each group. Co-expression analysis was performed to identify the co-expressed DEG-lncRNAs pairs. Different number of DEGs and differentially expressed lncRNAs were respectively identified from those 3 groups.NONHSAG013805(down-regulated) andNONHSAG009271(down-regulated) were common lncRNAs.NONHSAG013805was connected with the down-regulated gene EIF3E andNONHSAG009271was linked toMYL12A(down-regulated). Moreover,NONHSAG034203(up-regulated) was co-expressed withADM5(up-regulated) in low-grade NMI cancer, while the down-regulatedNONHSAG045391was connected with the down-regulated DEGsDAD1andSTUB1in high-grade NMI cancer and invasive bladder cancer. Our study indicates thatNONHSAG013805andNONHSAG009271may play key roles in bladder cancerviaco-expressing withEIF3EandMYL12A, respectively. Moreover,NONHSAG034203may be involved in low-grade NMI bladder cancerviatargetingADM5, whileNONHSAG045391may contribute to high-grade NMI and invasive bladder cancerviatargetingDAD1andSTUB1.